In this study, Yu et al. have generated novel FAP‐targeting CAR‐T cells and shown potent cytotoxicity against patient‐derived glioma neural stem cells, including the capacity to mediate ‘bystander’ killing of antigen‐negative target cells. The gene discussed is FAP; the disease is central nervous system cancer.